News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
David Gandara: Christine Lovly gives the opening address on “Eras of EGFR”
Photo taken from David Gandara/X
Feb 23, 2024, 17:24

David Gandara: Christine Lovly gives the opening address on “Eras of EGFR”

David Gandara, Director of Thoracic Oncology and Senior Advisor to the Director at University of California Davis Comprehensive Cancer Center (UCDCCC), shared a post on X/Twitter:

“IASLC TTLC24. Christine Lovly gives the opening address on “Eras of EGFR”. A visionary presentation. Bravo!”

Source: David Gandara/X

cancer Christine Lovly David Gandara Eras of EGFR IASLC OncoDaily Oncology
Insight
Aug 18, 2024, 01:43
Steven D Wexner: SEER database analysis of predictors of LN metastasis in neuroendocrone tumors
Blog
Aug 17, 2024, 08:58
Neha Mehta-Shah: Wonderful St. Louis tradition of the arts bringing together community!
Blog
Aug 17, 2024, 20:44
Palliative care is an added layer of support - Kidney CAN
Blog
Aug 17, 2024, 20:40
Register for HTTR24 - IASLC
Blog
Aug 17, 2024, 20:35
Nominate a colleague for a Fondazione Pezcoller - European Association for Cancer Research Award
Insight
Aug 17, 2024, 20:27
Andrea Carai: Our data suggest that VR is overall useful for pediatric neurosurgical oncology
Blog
Aug 17, 2024, 20:21
Dunkley’s will be lacing up their walking shoes for the Shine Night Walk in Bristol in support of Cancer Research UK - Dunkley's Chartered Accountants
Blog
Aug 17, 2024, 20:10
CANCaRe Africa's Voice of the families: Gashanew and his father
Blog
Aug 17, 2024, 20:07
Roche Africa CEO recently spoke of the care gap that exists throughout the African continent
Blog
Aug 17, 2024, 20:01
Miriam Mutebi: Cancer fatalism—the belief that cancer is incurable
Insight
Aug 17, 2024, 19:56
Oncotype DX Colon Recurrence Score in stage II colon cancer, summary by Erman Akkus
Blog
Aug 17, 2024, 19:53
First European Patient Dosed in Phase I Trial Of Novel CD30-Directed ADC FOR Lymphomas - The START Center for Cancer Research